Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Portilla

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Neurologia|September 4, 2024
Valproic acid could help in the fight against COVID-19: A case-control studyO Moreno-Pérez, E Merino, J Manuel Ramos, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 2015
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)S Monge, M Díez, M Alvarez, et al.
The Malaysian Journal of Pathology|April 29, 2022
Histopathological and virological features of lung, heart and liver percutaneous tissue core biopsy in patients with COVID-19: A clinicopathological case seriesJ M Ramos-Rincon, C Alenda, R García-Sevila, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 20, 2012
Lack of short-term increase in serum mediators of fibrogenesis and in non-invasive markers of liver fibrosis in HIV/hepatitis C virus-coinfected patients starting maraviroc-based antiretroviral therapyJ Macías, M M Viloria, A Rivero, et al.
HIV Medicine|January 15, 2014
Early lipid changes with atazanavir/ritonavir or darunavir/ritonavirE Martinez, A Gonzalez-Cordon, E Ferrer, et al.
Antiviral Research|November 28, 2009
Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study (Lake Study)P Echeverría, E Negredo, G Carosi, et al.
The Journal of Antimicrobial Chemotherapy|September 15, 2020
Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotypingM Casadellà, J R Santos, M Noguera-Julian, et al.
Open Forum Infectious Diseases|March 3, 2022
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)D Podzamczer, R Micán, J Tiraboschi, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Neurologia|September 4, 2024
Valproic acid could help in the fight against COVID-19: A case-control studyO Moreno-Pérez, E Merino, J Manuel Ramos, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 2015
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)S Monge, M Díez, M Alvarez, et al.
The Malaysian Journal of Pathology|April 29, 2022
Histopathological and virological features of lung, heart and liver percutaneous tissue core biopsy in patients with COVID-19: A clinicopathological case seriesJ M Ramos-Rincon, C Alenda, R García-Sevila, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 20, 2012
Lack of short-term increase in serum mediators of fibrogenesis and in non-invasive markers of liver fibrosis in HIV/hepatitis C virus-coinfected patients starting maraviroc-based antiretroviral therapyJ Macías, M M Viloria, A Rivero, et al.
HIV Medicine|January 15, 2014
Early lipid changes with atazanavir/ritonavir or darunavir/ritonavirE Martinez, A Gonzalez-Cordon, E Ferrer, et al.
Antiviral Research|November 28, 2009
Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study (Lake Study)P Echeverría, E Negredo, G Carosi, et al.
The Journal of Antimicrobial Chemotherapy|September 15, 2020
Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotypingM Casadellà, J R Santos, M Noguera-Julian, et al.
Open Forum Infectious Diseases|March 3, 2022
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)D Podzamczer, R Micán, J Tiraboschi, et al.
Pageof 13